← Leaderboards
Tyler Beck
Medical University Of South Carolina
$139,580
Attributed
$139,580
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49.1K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$139,580 · 1
By mechanism
F31$139,580 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Brent M Egan$2,811,640
- George Cooper$3,007,214
- Blase A Carabello$2,115,270
- Roger R Markwald$12,840,778
- Anand Ramamurthi$5,125,841
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectDouble-Blind MethodAntibioticsBiomechanicsAutomobile DrivingCanis FamiliarisCardiacCellsCell TypeChemistryClinical TrialsCollagenColorectal CancerComplete Blood CountComplexComputer AssistedControlled Clinical TrialsCytochromesDisease ModelDisease PathwayDisease ProgressionDockingDoseDrug Design
Grant awards (3)
Targeting Mek/Erk Signaling in the Treatment of Mitral Valve Prolapse$49,060
F31 · FY2023 · HL · contact PI
Targeting Mek/Erk Signaling in the Treatment of Mitral Valve Prolapse$45,618
F31 · FY2022 · HL · contact PI
Targeting Mek/Erk Signaling in the Treatment of Mitral Valve Prolapse$44,902
F31 · FY2021 · HL · contact PI